From April 1, 2023 to May 23, 2023, the company has repurchased 3,352,200 shares, representing 0.51% for CNY 46.93 million. With this, the company has completed the repurchase of 5,937,000 shares, representing 0.91% for CNY 100 million under the buyback announced on October 26, 2022.
Guangdong Hybribio Biotech Co.,Ltd.
Equities
300639
CNE100002N51
Medical Equipment, Supplies & Distribution
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
6.2 CNY | +2.31% | +1.47% | -33.62% |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-33.62% | 546M | |
+0.89% | 12.8B | |
-10.29% | 7.61B | |
+1.78% | 5.41B | |
-1.16% | 4.51B | |
+5.74% | 4.49B | |
-50.70% | 3.29B | |
+12.21% | 2.73B | |
-16.13% | 2.02B | |
-11.50% | 1.73B |
- Stock Market
- Equities
- 300639 Stock
- News Guangdong Hybribio Biotech Co.,Ltd.
- Tranche Update on Guangdong Hybribio Biotech Co.,Ltd.'s Equity Buyback Plan announced on October 26, 2022.